Authors:
Sanchorawala, V
Wright, DG
Seldin, DC
Dember, LM
Finn, K
Falk, RH
Berk, J
Quillen, K
Skinner, M
Citation: V. Sanchorawala et al., An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis, BONE MAR TR, 28(7), 2001, pp. 637-642
Authors:
Shen, J
Channavajhala, P
Seldin, DC
Sonenshein, GE
Citation: J. Shen et al., Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of I kappa B alpha, J IMMUNOL, 167(9), 2001, pp. 4919-4925
Authors:
Romieu-Mourez, R
Landesman-Bollag, E
Seldin, DC
Traish, AM
Mercurio, F
Sonenshein, GE
Citation: R. Romieu-mourez et al., Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappa B in breast cancer, CANCER RES, 61(9), 2001, pp. 3810-3818
Authors:
Choufani, EB
Sanchorawala, V
Ernst, T
Quillen, K
Skinner, M
Wright, DG
Seldin, DC
Citation: Eb. Choufani et al., Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy, BLOOD, 97(6), 2001, pp. 1885-1887
Authors:
Dember, LM
Sanchorawala, V
Seldin, DC
Wright, DG
LaValley, M
Berk, JL
Falk, RH
Skinner, M
Citation: Lm. Dember et al., Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease, ANN INT MED, 134(9), 2001, pp. 746-753
Citation: Dh. Song et al., Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells, J BIOL CHEM, 275(31), 2000, pp. 23790-23797